Showing 13–24 of 256 results
-
Alectinib
It’s meant for patients who have already been treated with crizotinib. Each of the hard capsules contains 33.7 mg of lactose and 6 mg of sodium. Alectinib should be administered only by a physician who has experience in using anti-cancer medicinal products. The dosage recommended for ALK-positive NSCLC patients is 600 mg (four capsules of 150 mg each) taken with food twice every day making it a total daily dose of 1200 mg.
-
Alimta
The Alimta 500 mg injection is administered to treat patients suffering from advanced nonsquamous non-small cell lung cancer simultaneously with chemotherapy to ensure that the effectiveness of initial treatment is maintained.
-
Altraz
It acts by lowering the estrogen level in the body. Altraz can also be used in advanced stages of breast cancer as a form of initial treatment either alone or in tandem with surgery or radiation. For maximum benefit, it is to be taken every day at the same time either with food or without it. It’s to be taken as advised by a doctor. The dosage depends on exactly what purpose it is being taken for.
-
Arimidex
It’s also suitable for use as a first line of treatment for advanced breast cancer that has spread to other parts of the body considerably. Belonging to the aromatase inhibitors class of drugs, Arimidex 1 mg tablets are meant for decreasing the estrogen amount in the bodies of patients. To get the maximum benefit from these tablets, they should be taken daily with or without food at the same time of the day.
-
Atgam
Before they are used for clinical purposes, every ATGAM lot is passed through tests to make sure that it can inhibit the formation of rosette between red blood cells of sheep and human peripheral lymphocytes in vitro. Antibody activity that’s against the red blood cells of humans and the platelets needs to be measured and it needs to be within the acceptable limits. Only the lots that show negative results for antihuman serum protein antibody, pyrogens, and anti-glomerular basement membrane are allowed for use.
50 mg of horse gamma globulin which is stabilized in 0.3 molar glycine to a pH of around 6.8 is what each millimeter of ATGAM contains.
Indications and Usage
Renal Transplantation ATGAM Sterile Solution is used to manage the rejection of allograft in patients of renal transplants. It’s meant to raise the frequency at which resolution of the acute rejection episode occurs during the rejection phase when it’s administered along with conventional therapy. To delay the start of the first rejection episode, the administration of the drug has been carried out as a supplement with other immunosuppressive therapy. To date, accumulated data haven’t consistently shown any improvement in functional graft survival linked to therapy which can delay the beginning of the initial rejection episode.
